Key facts today
AstraZeneca reported that its drug Enhertu has demonstrated improved progression-free survival (PFS) in patients with first-line HER2-positive metastatic breast cancer (mBC).
Hutchmed has finished enrolling 64 patients in a Phase II trial for savolitinib, developed with AstraZeneca, targeting gastric cancer. Positive results may prompt a marketing application in China.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
47.32 MXN
146.68 B MXN
1.13 T MXN
3.10 B
About ASTRAZENECA PLC ORD USD0.25
Sector
Industry
CEO
Pascal Soriot
Website
Headquarters
Cambridge
Founded
1992
FIGI
BBG00JX0NQ44
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Supply and Demand Trading Made Simple With Astrazeneca StockIn the ever-evolving world of stock trading, where news headlines can shift markets in a heartbeat, savvy investors often turn to the age-old principles of supply and demand to find clarity. Enter AstraZeneca stock (NASDAQ: AZN) — a biopharmaceutical titan that has played a pivotal role in global he
Astrazeneca potentially to $88AstraZeneca’s share price has been hovering around a long-term trend line established since 2017. Historically, each time the price has tested this trend line, it has rebounded sharply, suggesting strong investor confidence.
From 2017 to 2023, the company’s financial performance has been notably ro
BULLISH ON AZNAstraZeneca's Q3 2024 earnings exceeded expectations, with a revenue increase of 18%, signaling healthy demand for its products, especially in oncology and rare diseases.
Technicals - Key Indicators:
RSI (Relative Strength Index): Currently at 41.08, indicating strong bullish momentum but not ye
Astrazeneca (Wait for correction to complete)Hello,
To demonstrate how we can leverage TradingView for informed investment decisions, let’s analyze AstraZeneca as our example today. I will follow a structured approach and provide an investment recommendation based on both fundamental and technical insights.
Understanding the Business
Befor
AZN eyes on $71: Double Fib support that could launch a leg up AZN daily chart shows a significant pullback.
Currently testing a double Fib (Genesis+Covid).
Long entry option with a tight SL just below fibs.
$ 70.95-71.01 is the tight support of interest.
$ 80.48-81.11 would be an optimistic target.
===========================================
.
AstraZeneca - GBP | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Active Sessions on Relevant Range & Elemented Probabilities;
* Asian(Ranging) - London(Upwards) - NYC(Downwards)
* Weekend Crypto Session
Trend | Time Frame Conductive | Weekly Time Frame
- General Tr
AZN Astrazeneca plc ADRI’ve been closely monitoring AZN, which has been trading on the upside for a while now. Given the recent momentum, it appears to be approaching a point where a downward move could be imminent. I believe the stock might be ready to take a dip, presenting a potential opportunity for a downside play.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where AZN/N is featured.
Related stocks
Frequently Asked Questions
The current price of AZN/N is 1,343.00 MXN — it has decreased by −0.96% in the past 24 hours. Watch ASTRAZENECA GROUP PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ASTRAZENECA GROUP PLC stocks are traded under the ticker AZN/N.
AZN/N stock has risen by 0.032% compared to the previous week, the month change is a −12.91% fall, over the last year ASTRAZENECA GROUP PLC has showed a 17.49% increase.
We've gathered analysts' opinions on ASTRAZENECA GROUP PLC future price: according to them, AZN/N price has a max estimate of 2,228.47 MXN and a min estimate of 1,348.23 MXN. Watch AZN/N chart and read a more detailed ASTRAZENECA GROUP PLC stock forecast: see what analysts think of ASTRAZENECA GROUP PLC and suggest that you do with its stocks.
AZN/N stock is 1.18% volatile and has beta coefficient of 0.24. Track ASTRAZENECA GROUP PLC stock price on the chart and check out the list of the most volatile stocks — is ASTRAZENECA GROUP PLC there?
Today ASTRAZENECA GROUP PLC has the market capitalization of 4.10 T, it has increased by 8.93% over the last week.
Yes, you can track ASTRAZENECA GROUP PLC financials in yearly and quarterly reports right on TradingView.
ASTRAZENECA GROUP PLC is going to release the next earnings report on Apr 29, 2025. Keep track of upcoming events with our Earnings Calendar.
AZN/N earnings for the last quarter are 21.79 MXN per share, whereas the estimation was 21.58 MXN resulting in a 0.96% surprise. The estimated earnings for the next quarter are 22.84 MXN per share. See more details about ASTRAZENECA GROUP PLC earnings.
ASTRAZENECA GROUP PLC revenue for the last quarter amounts to 310.47 B MXN, despite the estimated figure of 296.62 B MXN. In the next quarter, revenue is expected to reach 283.30 B MXN.
AZN/N net income for the last quarter is 31.27 B MXN, while the quarter before that showed 28.16 B MXN of net income which accounts for 11.07% change. Track more ASTRAZENECA GROUP PLC financial stats to get the full picture.
Yes, AZN/N dividends are paid semi-annually. The last dividend per share was 21.05 MXN. As of today, Dividend Yield (TTM)% is 2.27%. Tracking ASTRAZENECA GROUP PLC dividends might help you take more informed decisions.
ASTRAZENECA GROUP PLC dividend yield was 2.32% in 2024, and payout ratio reached 66.98%. The year before the numbers were 2.11% and 73.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 22, 2025, the company has 94.3 K employees. See our rating of the largest employees — is ASTRAZENECA GROUP PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA GROUP PLC EBITDA is 366.85 B MXN, and current EBITDA margin is 33.02%. See more stats in ASTRAZENECA GROUP PLC financial statements.
Like other stocks, AZN/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA GROUP PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA GROUP PLC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA GROUP PLC stock shows the strong sell signal. See more of ASTRAZENECA GROUP PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.